MedTrace Logo

Monitoring Exhaled Propofol to Individualize General Anesthesia

NCT01191021 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-06-05

No results posted yet for this study

Summary

This trial investigates the relationship between concentrations of the anesthetic drug propofol in exhaled breath, blood and drug effect in volunteers undergoing general anesthesia. The main goal of this study is to develop a pharmacokinetic - and dynamic model for propofol in exhaled breath.

Conditions

  • General Anesthesia

Interventions

DRUG

Propofol Anesthesia

Volunteers will undergo propofol anesthesia for 90 min.

Sponsors & Collaborators

Principal Investigators

  • Christian C Apfel, MD, PhD · Perioperative Clinical Research Core, Department of Anesthesia, University of California San Francisco

  • Cyrill Hornuss, MD · Perioperative Clinical Research Core, Department of Anesthesia, University of California San Francisco

Study Design

Allocation
NA
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01191021 on ClinicalTrials.gov